TOG Review (RCOG Journal)

MRCOG Part 2

Antenatal Care

Prenatal genomic testing for ultrasound-detected fetal structural anomalies

Key Statistics

  • 3–5% — Pregnancies affected by FSA
  • 0.5% — Miscarriage risk, invasive testing
  • ≤80% — Max diagnostic yield, exome sequencing

Don't-miss facts

  1. FSAs affect 3–5% of pregnancies; ~50% have a genetic/chromosomal cause

  2. Testing order: QF-PCR (48h) → karyotype (~10d, gold standard for mosaicism/rearrangements) or CMA (10–14d, +3.5– 6% yield) → trio exome sequencing (10–14d)

  3. CMA offered with normal QF-PCR plus NT ≥3.5 mm (CRL 45–84 mm), ≥1 FSA, or unexplained sex chromosome aneuploidy; commonest CNV = 22q11.2 deletion

  4. PAGE study (n=610): diagnostic ES yield 8.5%, VUS 3.9%; key genes KMT2D, CHD7, PTPN11

  5. R21 rapid exome requires normal QF-PCR + CMA first; not used if TOP decided or fetal demise imminent

  6. Only class IV/V variants reported as diagnostic (Sanger-validated); VUS not reported but may be reclassified

  7. Invasive testing miscarriage risk 0.5%; maternal cell contamination 1–2%

  8. Recurrence: autosomal recessive 1/4, autosomal dominant 1/2, gonadal mosaicism up to 4% even if "de novo"

Testing tiers at a glance

QF-PCR 48h → ~25% yield CMA 10–14d → +3.5–6% yield Exome sequencing 10–14d → up to 80% (selected)

Abbreviation Key

  • FSA — fetal structural anomaly
  • FISH — fluorescence in situ hybridization
  • QF-PCR — quantitative fluorescence-polymerase chain reaction
  • CVS — chorionic villus sampling
  • CMA — chromosome microarray
  • TAT — turnaround time
  • CGH — comparative genomic hybridisation
  • NT — nuchal translucency
  • SNP — single nucleotide polymorphism
  • MDT — multidisciplinary team
  • CNV — copy number variant
  • NIPD — non-invasive prenatal diagnosis
  • NGS — next generation sequencing
  • PGD — preimplantation genetic diagnosis
  • ES — exome sequencing
  • RCOG — Royal College of Obstetricians and Gynaecologists
  • WGS — whole genome sequencing
  • PAGE — Prenatal Assessment of Genomes and Exomes study
  • VUS — variant of uncertain significance
  • R21 — NHS England rapid prenatal exome test code

Source: Reilly K et al. Prenatal genomic testing for ultrasound-detected fetal structural anomalies. The Obstetrician & Gynaecologist 2023;25:121–130. doi:10.1111/tog.12870

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free